Skip to content
ProPublica Donate
ProPublica Donate
Regulation

Toxic Burden

How American Chemical Regulations Failed the Public

The United States designed its chemical regulation system to keep businesses humming with little interference. That decision had health repercussions for ordinary Americans, who are left to carry the burden.

Impact of Our Reporting
Caret

Toxic Burden

The Federal Government Plans to Reform “Star” Workplace Safety Program That Reduced Inspections at Some Manufacturers

After ProPublica raised questions about the rigor of inspections at Star Program facilities that used asbestos but received limited unannounced OSHA visits, regulators are seeking input about how to reform it.

Toxic Burden

Major Chemical Company Changes Tune on Asbestos, No Longer Opposes EPA Ban

In a letter to the EPA, Olin Corp., one of the few U.S. manufacturers still using asbestos, signaled newfound support for a federal ban on the deadly mineral and said it could halt imports as soon as this week.

Toxic Burden

Lawmakers Have Renewed the Effort to Ban Asbestos

They said ProPublica’s recent reporting on unsafe conditions in factories that use asbestos underscores the need for action.

Toxic Burden

EPA Asks for More Public Input on Asbestos After ProPublica and Others Reveal New Information

In an unusual move, the EPA opened a new public comment period on its proposed asbestos ban to get input regarding new information, including ProPublica findings that workers were “swimming” in the deadly substance.

Toxic Burden

Public Health Leaders Question Whether Asbestos Facilities Should Be Exempt From Surprise Inspections

The American Public Health Association raised concerns that plants “game the system” to hide asbestos problems and called for scrutiny from the Occupational Safety and Health Administration.

Toxic Burden

Workers Across America Break Their Silence on Decades of Asbestos Exposure

New accounts from workers contrast sharply with what chemical giants have said on the record about worker safety at their facilities.

Toxic Burden

Lawmakers and Public Health Advocates Call for Congress to Finally Ban Asbestos

A law blocking the use of asbestos, a potent carcinogen, would be harder to overturn than a similar ban being considered by the EPA, advocates say.

What We’re Watching

During Donald Trump’s second presidency, ProPublica will focus on the areas most in need of scrutiny. Here are some of the issues our reporters will be watching — and how to get in touch with them securely.

Learn more about our reporting team. We will continue to share our areas of interest as the news develops.

Photo of Sharon Lerner
Sharon Lerner

I cover health and the environment and the agencies that govern them, including the Environmental Protection Agency.

Photo of Andy Kroll
Andy Kroll

I cover justice and the rule of law, including the Justice Department, U.S. attorneys and the courts.

Photo of Melissa Sanchez
Melissa Sanchez

I report on immigration and labor, and I am based in Chicago.

Photo of Jesse Coburn
Jesse Coburn

I cover housing and transportation, including the companies working in those fields and the regulators overseeing them.

If you don’t have a specific tip or story in mind, we could still use your help. Sign up to be a member of our federal worker source network to stay in touch.

We’re trying something new. Was it helpful?

Most Read

    The DEA Once Touted Body Cameras for Their “Enhanced Transparency.” Now the Agency Is Abandoning Them.

    An internal email obtained by ProPublica said the agency made the change to be “consistent” with a Trump executive order. But at least two other federal law enforcement agencies are still requiring body cameras.

    The Price of Remission

    When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.

    Inside Project 2025’s Secret Training Videos

    “Eradicate climate change references”; only talk to conservative media; don’t leave a paper trail for watchdogs to discover. In a series of never-before-published videos, Project 2025 details how a second Trump administration would operate.

    Why Do Americans Pay More for Prescription Drugs?

    Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those companies that sell their drugs at higher prices than the average of the prices in other wealthy nations.

    Democratic Lawmakers Blast Trump Administration’s VA Cuts After ProPublica Investigation

    The lawmakers also accused Veterans Affairs Secretary Doug Collins of stonewalling their efforts to learn more about agency cuts and their effects. “There are real-life dangerous impacts for veterans,” Rep. Chris Deluzio said.

OSZAR »